ALKERMES PLC (ALKS:NASDAQ)
$43.75 -0.43 (-0.9733%)
Analysed ALKERMES PLC (ALKS:NASDAQ) News Sources
An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slide
22-09-2026
biopharmadive.com
Alkermes Posts Positive Data From Phase I ADHD Study on ALKS 7290
22-09-2026
yahoo.com
Alkermes ADHD Data Boosts Confidence in ALKS7290, Orexin Pipeline, RBC Says
22-09-2026
yahoo.com
Alkermes (ALKS) Reports Early ADHD Drug Results. Can a Larger Trial Show it Works?
26-09-2026
yahoo.com
LQDA versus ALKS: Which Biotech Stock Is the Better Buy Now?
30-09-2026
yahoo.com
Why Baird Sees Promising Growth Potential in Alkermes plc (ALKS)
05-10-2026
yahoo.com
Alkermes (ALKS) Holds To Its Narrative, Is The Pullback A Buying Opportunity?
09-10-2026
yahoo.com
Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research
13-10-2026
yahoo.com
Earnings Preview: Alkermes (ALKS) Q3 Earnings Expected to Decline
20-10-2026
yahoo.com
Alkermes to Report Third Quarter Financial Results on November 3, 2026
20-10-2026
yahoo.com
What is the current price of ALKERMES PLC (ALKS:NASDAQ)?
The current price of ALKERMES PLC (ALKS:NASDAQ) is $43.75.
ALKERMES PLC (ALKS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALKERMES PLC (ALKS:NASDAQ) since the previous trading day is $-0.43.
ALKERMES PLC (ALKS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALKERMES PLC (ALKS:NASDAQ) since the previous trading day is -0.9733%.
What is the most recent average sentiment score for ALKERMES PLC (ALKS:NASDAQ)?
The most recent average sentiment score for ALKERMES PLC (ALKS:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for ALKERMES PLC (ALKS:NASDAQ)?
The most recent sentiment for ALKERMES PLC (ALKS:NASDAQ) is .
SEC-8K** Filing Available For ALKERMES PLC (ALKS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.